News Center

Home page

Peak Report

News reports

The company takes stock of the work in the first quarter and puts forward the work requirements for the second quarter.

Release time:

2020-08-14

Company Counts Work in the First Quarter and Proposes Work Requirements for the Second Quarter

News 4# July 17 and 18 , the Company successively held work analysis meetings for cement sector, pharmaceutical industry, international trade and cable companies to summarize the gains and losses of the work in the first quarter and put forward requirements for the next stage, especially the work in the second quarter. At the

analysis meeting, the person in charge of each enterprise reported the work situation in the first quarter in the form of PPT , focusing on analyzing the existing problems and proposing solutions and improvement plans. Chairman Jiang Xiaomeng, general manager Yu Jianhong and other group company leaders commented on the work of each business sector one by one based on the economic and technical data of each enterprise in the first quarter, pointed out the highlights of the work, analyzed the problems and deficiencies, and put forward guidance and work requirements.

Cement Plate: Optimize Structure, Improve Efficiency, Insist on Maximizing Benefits

In the first quarter, the overall benefits of the two peak cement enterprises increased year on year. Removing the factor of rising coal prices, various production indicators such as kiln production, cement mill production and power consumption per ton of clinker were improved, and the optimization of management organizations and posts was also steadily advancing. The company leaders pointed out that the future competition in the cement industry will be more cruel. Jianfeng Cement must clarify its thinking, seize the current more favorable opportunity, strengthen its own strength, adhere to the principle of maximizing benefits, strengthen the construction of core profit areas, and strive to achieve a balance of production and sales while striving for Greater profit space. The

meeting required the two cement companies to adjust the balance between the product structure and the target market in terms of sales according to the actual situation of the company and the development trend of the cement industry in the region, so as to improve the comprehensive gross profit and lay a good foundation for the continued stability of the market in the future. In terms of internal management, while strengthening the optimization of institutions and posts, carefully sort out and improve the functions and responsibilities of departments, teams and posts, and standardize the work process and work standards in detail; combine internal training with external training, strengthen the training of employees' knowledge of cement production technology and equipment, and comprehensively improve the overall quality of employees; strengthen equipment maintenance and management, equipment maintenance standards, procurement and storage of spare parts, and equipment replacement cycles must be strictly and scientifically controlled, and problems must be deeply summarized to effectively improve the reliability and stability of equipment operation; strengthen technical research and technological transformation, and continue to introduce And use new technologies to further optimize and improve various production indicators; improve the implementation of responsibilities and evaluation incentive mechanisms, ensure that every control index and the requirements of every production link can be consciously implemented in the post, so that the work is consistent with the evaluation and assessment, and the enthusiasm of the whole staff is improved. In terms of environmental protection and safety management, it is necessary to eliminate fluke mentality, earnestly implement the safety and environmental protection responsibility system at all levels, increase investment in related facilities, equipment and technical transformation, strengthen self-inspection and self-correction of habitual violations, and earnestly implement the hazardous environment operation ticket system. Optimize the actual situation and revise and improve the safety work procedures to ensure safe and orderly production.

According to the specific conditions of the two enterprises, the company leaders also requested Daye Peak to further strengthen daily inspection and maintenance to avoid overload operation of equipment and reduce unstable factors affecting production. Yunnan Peak should adjust its sales strategy in rainy season in advance to ensure the balance of production and sales and market stability.

Peak Pharmaceutical Industry: Finding Gaps, Setting Benchmarks, Brave Innovation, Seeking Breakthrough

With the further deepening of medical system reform, drug consistency evaluation and the implementation of the "two-vote system", the production and operation of pharmaceutical enterprises are facing many new pressures. At the analysis meeting, the company leaders asked the pharmaceutical company to recognize the policy changes and the development trend of the industry, seriously think about the future work with a higher height, wider vision and longer-term vision, deeply analyze the gap with the advanced enterprises in the same industry, select the benchmark, solve their own shortcomings and problems point to point, and seek breakthroughs.

In terms of sales, we must boldly innovate marketing mechanisms and methods, boldly use talents, give full play to the enthusiasm of sales staff, increase assessment efforts, carry out precise incentives, and seek sales breakthroughs; according to the specific conditions of each product, Do a good job of bidding with the idea of long-term benefit planning to lay the foundation for market expansion and product volume. In terms of production, we should firmly establish the purpose of serving all for sales, pay close attention to cost management on the premise of ensuring quality, and strive to reduce production costs by improving the yield, one-time pass rate and quality rate. In terms of product development, boldly introduce new varieties with market and technical advantages, and accelerate the promotion of consistency evaluation and other related work. In terms of internal management, we should make forward-looking information investment, improve the level of information construction, and improve operational efficiency; boldly employ new people, train, select and enrich the talent team; continue to promote the optimization of internal management structure and team building, and strive to innovate in working ideas and working methods, so as to realize the self-improvement and transformation of the team. In terms of project promotion, accelerate the implementation of international certification, Jinder, artificial bezoar and other work, and pay close attention to and track the operation of Huibaoyuan and other enterprises. The meeting also asked pharmaceutical companies to implement the division of labor and clear responsibilities from the members of the management team, so as to make the whole organizational structure operate more smoothly and efficiently.

International Trade Company: Find the correct positioning and development direction, strengthen management, and improve service quality

Company leadership requirements, international trade companies must clarify the goal and direction of "modern logistics", and combine the actual situation of the company, Carry out various tasks in a targeted manner, form a business model with advantages and own characteristics, and strengthen the construction of a talent team that is compatible with its own positioning; on the existing basis, continue to improve old business, expand new business, and extend the business chain; strengthen internal management, improve management standardization, and improve service quality; strengthen the cultivation of sense of responsibility and mission, reduce management levels, implement precise incentives, and give full play to The enthusiasm of employees; sort out and formulate various systems based on the principles of operability and efficiency, eliminate management loopholes, and reduce operating costs.

Peak Cable: Thrift and Thrift, Maintain Stability

Cable Company's overall production and operation in the first quarter was stable. The company's leaders required the management team to do a good job in the management of assets, personnel, safe production and receivables, organize and carry out various tasks such as procurement, production and sales with the idea of "thrifty and thrifty", strive to reduce production costs and lay a good foundation for future transformation.

The first quarter job analysis meeting of Spike Health Technology will be held at a later date. (Reporter Fu Yiwu)

More information

Yunnan peak through the safety standard secondary acceptance

On March 21, Yunnan Jianfeng Cement Company successfully passed the evaluation and acceptance of secondary enterprises for safety production standardization. On the same day, a review team composed of leaders of the Yunnan Provincial Work Safety Supervision Bureau and relevant experts reviewed the implementation of the establishment of Yunnan Jianfeng safety production standardization secondary enterprises. According to the 13 elements involved in the "Standard for Assessment and Rating of Safety Production Standardization in Cement Enterprises", the review team conducted strict assessment and scoring item by item through grouping to check the site and review the data, and finally determined that Yunnan Peak passed the standard acceptance of safety standardization secondary enterprises. Yunnan Jianfeng has always attached great importance to safety production. After passing the three-level safety standard enterprise review in 2015, in order to raise the level of enterprise safety management to a new level, in 2016, it began to create secondary safety standardization. Over the past year, Yunnan Jianfeng has insisted on taking the creation of secondary safety standards as the top priority of production and operation management, and has formulated an implementation plan for production safety standardization in accordance with the requirements of national standardization norms. the content covers production safety responsibility system, education and training, safety inspection, safety facilities management and other safety production management standards, systems and post safety operation procedures, while further strengthening daily safety inspection and regularly organizing emergency plan drills, strengthen the investigation and rectification of potential safety hazards and the supervision of important hazard sources, and further consolidate the foundation of enterprise safety production management. After the review, Zhou Jiping, general manager of Yunnan Jianfeng, said that Yunnan Jianfeng will take this standard as a new starting point. On the basis of consolidating the accident-free achievements in production safety for two consecutive years, it will conscientiously implement the main responsibility of production safety and cultivate

2020

07-30

Pharmaceutical Company Invests in Beihui Bio-Peak Pharmaceutical Plate to Expand its Territory

News from our newspaper On February 28, the 10th meeting of the 9th Board of Directors of the Group Company reviewed and approved the "Proposal on Foreign Investment of Subsidiaries" and the "Proposal on Authorizing the Chairman of the Board of Directors." On the same day, Jianfeng Pharmaceutical signed the "Agreement on Capital Increase and Share Transfer of Beijing Huibaoyuan Biotechnology Co., Ltd." and the "Performance Commitment Compensation Agreement" with relevant parties. It is planned to use Beijing Huibaoyuan Biotechnology Co., Ltd. (Beihui Biotechnology) and its holding subsidiary Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. (Guanghui Pharmaceutical) as a platform to jointly carry out new drug research and development, drug production and operation and other pharmaceutical business cooperation. Beihui Biological formerly known as Beijing Huibaoyuan Biotechnology Co., Ltd. The company has strong capabilities in new drug research and development. The actual controller is James Zhou (Zhou Hua), a returned entrepreneurial Ph.D. from Yale University in the United States, and hired Professor Zheng Yongqi from Yale University in the United States as the director of the Huibaoyuan Science and Technology Committee, focusing on anti-tumor and liver disease research. Through the cooperation with Yale University, we have obtained the patent authorization and commercial development license of the new anti-cancer chemical drug trasatabine (trokacitabine)(which has obtained the national new drug clinical approval in August 2016), the anti-hepatitis B chemical drug Crevudine (Clevudine). Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd., a subsidiary of Beihui Biology, is located in the third international park "China-Malaysia Qinzhou Industrial Park" jointly built by the Chinese government and foreign governments in Guangxi. It covers an area of 214.46 mu and has production workshops for multiple dosage forms such as percolation, tincture, solid preparations and liquid preparations.

2020

07-31

Peak health marketing and a new "play"

Building a New System, Flattening Management, Spike Health Marketing, New "Fit" On February 17, Spike Health Technology Company held a sales meeting to integrate and adjust the construction of a new marketing system and deploy and implement the 2017 sales work. Chen Daiyou, general manager of Health Technology Company, carefully explained and answered the marketing system construction and sales management assessment methods at the meeting, and reached a consensus on unifying thinking. The sales business of Health Technology Company involves three categories: health care products, plant extracts and Chinese herbal pieces. The product attributes and categories are different, and the product sales channels are diversified. In order to facilitate market expansion and adapt to the rapid response to market changes, the Company focuses on key products, key channels and key markets, adjusts the original division model, combines all sales businesses of the Company, establishes a marketing center, and centralizes and unifies flat management. At the meeting, the Health Technology Company issued the "2017 Sales Management Assessment Measures", which takes sales performance as the leading factor, defines the sales staff's business expenses and market expansion support policies, implements quarterly and annual assessment of sales targets, and directly links the assessment of the progress of sales staff's target tasks with monthly income. After two-way selection, adjustment and implementation of sales positions and target tasks, all sales staff of Health Technology Company have signed a sales economic responsibility system. Chen Daiyou hopes that marketers will build confidence to meet the challenges and grow and progress together with the enterprise. At the same time, he said that the health technology company will focus on strengthening the construction and cultivation of the sales team, and carry out training, learning and experience sharing in various ways, so as to improve the business ability and level of the sales team. (Spike Health)

2020

07-31

Peak health marketing and a new "play"

Building a New System, Flattening Management, Spike Health Marketing, New "Way to Work" On February 17, Spike Health Technology Company held a sales meeting to integrate and adjust the construction of a new marketing system and deploy and implement the 2017 sales work. Chen Daiyou, general manager of Health Technology Company, carefully explained and answered the marketing system construction and sales management assessment methods at the meeting, and reached a consensus on unifying thinking. The sales business of Health Technology Company involves three categories: health care products, plant extracts and Chinese herbal pieces. The product attributes and categories are different, and the product sales channels are diversified. In order to facilitate market expansion and adapt to the rapid response to market changes, the Company focuses on key products, key channels and key markets, adjusts the original business model, unifies all sales businesses of the Company, establishes a marketing center, and centralizes and unifies flat management. At the meeting, the Health Technology Company issued the "2017 Sales Management Assessment Measures", which takes sales performance as the leading factor, defines the sales staff's business expenses and market expansion support policies, implements quarterly and annual assessment of sales targets, and directly links the assessment of the progress of sales staff's target tasks with monthly income. After two-way selection, adjustment and implementation of sales positions and target tasks, all sales staff of Health Technology Company have signed a sales economic responsibility system. Chen Daiyou hopes that marketers will build confidence to meet the challenges and grow and progress together with the enterprise. At the same time, he said that the health technology company will focus on strengthening the construction and cultivation of the sales team, and carry out training, learning and experience sharing in various ways, so as to improve the business ability and level of the sales team. (Spike Health)

2020

07-31

Accident-free factory creation enters "second season"

At the beginning of the new year, a major "highlight" of the company's safety and environmental protection management in recent years-the "second quarter" of the establishment of a safety and environmental protection accident-free factory has also begun. Safety and environmental protection accident-free factory creation activities are an important measure for the company to improve the level of on-site management. The first phase of the activity will start on January 1, 2014 and end at the end of 2016 for a period of three years. Since the launch of the activity, all subordinate enterprises of the company have actively organized publicity and training related to safety and environmental protection, strengthened the awareness of safety and environmental protection of all employees, improved the management and operation level of safety and environmental protection; increased investment in safety and environmental protection facilities and equipment; strengthened safety and environmental protection inspection and self-examination and correction of hidden dangers, and timely organized rectification of hidden dangers; strictly assessed the units and relevant responsible persons of the accident, And the accident situation in the group, in order to arouse vigilance and avoid similar accidents. In the past three years, the company's subsidiaries have achieved remarkable results in standardization, safety, and clean operation. Safety and environmental protection accidents have dropped significantly, and no major accidents have occurred, which has effectively promoted the company's safe and civilized production construction. In the 2016 safety and environmental protection accident-free factory establishment assessment conducted a few days ago, a total of 6 units met the accident-free factory standard, of which Yunnan Jianfeng, Jianfeng International Trade and Pharmaceutical Department met the standard for the second consecutive year, and Daye Jianfeng, Qiubin Factory and Cable Company met the standard in the first year. In order to sum up experience and further improve the level of safety and environmental protection management, the Group decided to continue to open

2020

07-31

What will the Chinese Medicine Act bring us?

At the 25th meeting of the Standing Committee of the 12th National People's Congress in December 2016, the the People's Republic of China Chinese Medicine Law (hereinafter referred to as the Chinese Medicine Law) was deliberated and passed, which will come into effect on July 1 this year. As the first comprehensive law that comprehensively and systematically embodies the characteristics of traditional Chinese medicine, the Law of traditional Chinese Medicine clearly stipulates the service of traditional Chinese medicine, the protection and development of traditional Chinese medicine, the training of talents of traditional Chinese medicine, and the scientific research of traditional Chinese medicine. With the change of people's health concept and the continuous innovation of medical mode in recent years, the role of traditional Chinese medicine in health is becoming more and more important. The promulgation of the "Traditional Chinese Medicine Law" has made the development of Chinese medicine more law-based, and it is bound to bring changes to domestic pharmaceutical companies. So, the peak of the pharmaceutical, health products companies will look at the "Chinese Medicine Law", and will have how to deal with it? A few days ago, the reporter interviewed the pharmaceutical companies and peak health technology companies related to the person in charge. What will the Chinese Medicine Act bring us? Reporter: As the general manager of Peak Pharmaceutical, what do you think of the Chinese Medicine Law? Huang Jinlong (Deputy General Manager of the Group Company and General Manager of the Pharmaceutical Company): the Law of traditional Chinese Medicine defines the important position and development policy of traditional Chinese medicine. The state encourages traditional Chinese medicine and western medicine to learn from each other, complement each other, coordinate development, give full play to their respective advantages, and promote the integration of traditional Chinese and western medicine. Traditional Chinese medicine is a huge knowledge system, reflecting the Chinese nation's understanding of life, health and disease. It is precisely because of the distinctive characteristics of Chinese medicine that the Law of Chinese Medicine is used in Chinese medicine clinics, Chinese medicine physicians and doctors.

2020

07-31

< 1...49 50 51...61 > 跳转到页